Effectively treat chronic wounds
Chronic wounds, primarily venous leg ulcers and foot ulcers in diabetic patients, affect more than 10 million people in the US and in Europe. The average healing time for these patients exceeds 200 days, constituting a major public health problem.
Device designed to be easy to use, with a lightweight and compact casing.
Intended use by healthcare professionals in hospitals and at patients' homes.
LEARN MORE
LEARN MORE
Improving the quality of life of patients with chronic wounds
Limits infections and hospitalizations
Makes the work of healthcare professionals easier
Reduces the cost of health insurance coverage
Cold plasma, an innovation for painless treatment
The clinical benefits of cold plasma have already been demonstrated by years of research. It allows a non-invasive treatment of chronic wounds by stimulating the pillars of healing and triggering an antiseptic action.
LEARN MORE
LEARN MORE
2023
Preclinical studies validating the effectiveness of the device
2024
Development of the industrial version of the device
2025
1st clinical investigation on humans
2026
Obtaining CE marking and launching marketing